MS42 IMPROVED LIPID REDUCTION AND TARGET ATTAINMENT WITH...

Atherosclerosis Supplements 2010 / 6 Vol. 11; Iss. 2

MS42 IMPROVED LIPID REDUCTION AND TARGET ATTAINMENT WITH EZETIMIBE/SIMVASTATIN VERSUS ROSUVASTATIN IN HIGH-RISK PATIENTS FAILING PRIOR STATIN THERAPY: AGE FACTOR

Missault, L., Vaverkova, H., Farnier, M., Averna, M., Viigimaa, M., Dong, Q., Shah, A., Taggart, W., Brudi, P.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
11
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/s1567-5688(10)70543-2
Date:
June, 2010
File:
PDF, 57 KB
english, 2010
Conversion to is in progress
Conversion to is failed